Texas Instruments reports Q2 revenue down 16% YoY to $3.82B and forecasts Q3 revenue in line with analysts' estimates of $4.14B, easing fears of a chip downturn
Ian King / Bloomberg :
Context & Ripple Effects
Texas Instruments entered this quarter after a prolonged demand reset: its first quarterly sales decline after the 2020 growth run was followed by worsening industrial demand and a below-consensus fourth-quarter outlook.
The company’s roughly 13% full-year sales decline in 2023 established the depth of the correction. A third-quarter forecast that matches expectations therefore matters less as evidence of renewed growth than as a sign that the near-term deterioration may be becoming more predictable.
First-order effects
- Texas Instruments remains in a year-over-year contraction, with Q2 revenue down 16%, but its Q3 outlook removes an immediate downside surprise versus the analyst consensus.
- Investors and customers get a clearer near-term demand signal from a major supplier to industrial and automotive markets, reducing the urgency implied by fears of a sharper sector-wide drop.
Second-order effects
- Peers with similar exposure to industrial and automotive chips may face less pressure to reset near-term expectations if Texas Instruments’ outlook proves representative, though the report does not establish a broad recovery.
- For equipment makers and component buyers, steadier supplier guidance can support inventory planning after a period in which weak end demand drove repeated forecast cuts.
Third-order effects
- If successive quarters move from worsening guidance to in-line guidance before returning to growth, the semiconductor cycle may shift from inventory correction toward a slower normalization rather than a rapid rebound.
- The episode underscores how mature-chip demand can follow a different cadence from AI-led semiconductor spending, making broad “chip cycle” readings less useful without segment-level evidence.
The trend: This is one data point in the contracted semiconductor cycle’s transition from broad demand weakness toward uneven stabilization across end markets.